Literature DB >> 26926584

The Role of Platelets in Venous Thromboembolism.

Silvia Montoro-García1, Marc Schindewolf2, Sophia Stanford3, Ole Halfdan Larsen4, Thomas Thiele5.   

Abstract

Multiple factors contribute to the risk of venous thromboembolism (VTE). Platelets have attracted much interest in arterial cardiovascular disease, whereas their role in VTE has received much less attention. Recent evidence suggests that platelets may play a more important role in VTE than previously anticipated. This review discusses the mechanisms that link platelets with venous thrombotic disease and their potential applications as novel risk factors for VTE. In addition, animal studies and randomized clinical trials that highlight the potential effect of antiplatelet therapy in venous thrombosis are evaluated to assess the role of platelets in VTE. The clinical significance of platelets for VTE risk assessment in specific patient cohorts and their role as a suitable therapeutic target for VTE prevention is acknowledged. The role of platelets in VTE is a promising field for future research. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926584     DOI: 10.1055/s-0035-1570079

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  17 in total

1.  Predicting venous thrombosis in patients undergoing elective splenectomy.

Authors:  Peter Szasz; Ali Ardestani; Brent T Shoji; David C Brooks; Ali Tavakkoli
Journal:  Surg Endosc       Date:  2019-07-29       Impact factor: 4.584

Review 2.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  The interaction of vortical flows with red cells in venous valve mimics.

Authors:  Zyrina Alura C Sanchez; Vignesha Vijayananda; Devin M Virassammy; Liat Rosenfeld; Anand K Ramasubramanian
Journal:  Biomicrofluidics       Date:  2022-03-03       Impact factor: 2.800

4.  Blood type, ABO genetic variants, and ovarian cancer survival.

Authors:  Gabriella D Cozzi; Rebecca T Levinson; Hilary Toole; Malcolm-Robert Snyder; Angie Deng; Marta A Crispens; Dineo Khabele; Alicia Beeghly-Fadiel
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 5.  Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives.

Authors:  Chao Yan; Xiaohua Wang; Hua Su; Kejing Ying
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

6.  p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis.

Authors:  Xiamin Wang; Sixuan Zhang; Yangyang Ding; Huan Tong; Xiaoqi Xu; Guangyu Wei; Yuting Chen; Wen Ju; Chunling Fu; Kunming Qi; Zhenyu Li; Lingyu Zeng; Kailin Xu; Jianlin Qiao
Journal:  Redox Biol       Date:  2020-05-11       Impact factor: 11.799

7.  Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway.

Authors:  Guangyu Wei; Xiaoqi Xu; Huan Tong; Xiamin Wang; Yuting Chen; Yangyang Ding; Sixuan Zhang; Wen Ju; Chunling Fu; Zhenyu Li; Lingyu Zeng; Kailin Xu; Jianlin Qiao
Journal:  Aging (Albany NY)       Date:  2020-04-30       Impact factor: 5.682

8.  Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study.

Authors:  Chen Yao; Zhe Zhang; Yao Yao; Xingquan Xu; Qing Jiang; Dongquan Shi
Journal:  J Orthop Surg Res       Date:  2018-02-27       Impact factor: 2.359

Review 9.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05

Review 10.  Interplay between platelets and coagulation.

Authors:  Yaqiu Sang; Mark Roest; Bas de Laat; Philip G de Groot; Dana Huskens
Journal:  Blood Rev       Date:  2020-07-12       Impact factor: 10.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.